AMACR and urogenital neoplasm: AMACR overexpression is an early event in prostate carcinogenesis and indicate malignant transformation.7,20 AMACR could be one of the immune markers that have role in distinguishing ordinary and aggressive prostate cancer and this would improve our understanding of prognostic values.5